Jove
Visualize
Contact Us

Related Concept Videos

Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

11.0K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K
Autophagy01:27

Autophagy

5.8K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.8K
Feedback Inhibition00:46

Feedback Inhibition

57.1K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.1K
Enzyme Inhibition01:30

Enzyme Inhibition

91.9K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
91.9K
What is Natural Selection?01:32

What is Natural Selection?

128.1K
Natural selection is an evolutionary process in which individuals with survival-promoting traits reproduce at higher rates. These favorable traits become more common within a population or species. Naturally selected traits initially arise via random genetic mutations. In order for selection to occur, there must be variation within a population, the trait controlling the variation must be heritable, and there must be an evolutionary advantage for variation in the trait.
128.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

6.0K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stepwise Differentiation of Mouse Embryonic Stem Cells Into Murine Blood Vessel Organoids With Endothelial Lineage Tracing for Quality Control.

Bio-protocol·2026
Same author

Development and reliability testing of BRANT-MERQS-2A: A quality assessment tool for medication review type 2a reports.

International journal of clinical pharmacy·2026
Same author

The INSPIRE doctoral network in safety pharmacology - Looking back and ahead.

Journal of pharmacological and toxicological methods·2026
Same author

Binding Mechanism of UAMC-1110 to Fibroblast Activation Protein.

Journal of chemical information and modeling·2026
Same author

Identification of small-molecule autophagy activators via GFP-LC3 high-throughput screening and a cargo-based autophagy flux and processing assay.

European journal of pharmacology·2026
Same author

ERBB4 activation as a new therapy for atrial remodeling and fibrillation.

Heart rhythm·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jan 28, 2026

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
09:51

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells

Published on: June 30, 2023

1.4K

Vectorized ULK1/2 and VPS34 Inhibitors for Tissue-Selective Autophagy Inhibition in Oncology.

Lorenzo Cianni1, Kathryn Jacobs2,3, Sergei Grintsevich1

  • 1Laboratory of Medicinal Chemistry (UAMC), Department of Pharmaceutical Sciences, University of Antwerp, 2610 Wilrijk, Belgium.

Journal of Medicinal Chemistry
|January 26, 2026
PubMed
Summary
This summary is machine-generated.

Researchers developed novel tumor-targeted autophagy inhibitors to selectively block cancer cell survival mechanisms. These compounds show promise for cancer therapy by inhibiting autophagy specifically in tumors while sparing healthy tissues.

More Related Videos

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts
09:21

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts

Published on: February 23, 2024

1.5K
Activating Autophagy by Aerobic Exercise in Mice
08:44

Activating Autophagy by Aerobic Exercise in Mice

Published on: February 3, 2017

12.7K

Related Experiment Videos

Last Updated: Jan 28, 2026

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
09:51

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells

Published on: June 30, 2023

1.4K
Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts
09:21

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts

Published on: February 23, 2024

1.5K
Activating Autophagy by Aerobic Exercise in Mice
08:44

Activating Autophagy by Aerobic Exercise in Mice

Published on: February 3, 2017

12.7K

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Autophagy is a key cellular process crucial for survival and homeostasis.
  • Tumors exploit autophagy for plasticity, adaptation, and therapy resistance, making it a therapeutic target.
  • Selective autophagy inhibition in tumors is essential due to its vital role in healthy tissues.

Purpose of the Study:

  • To design and validate tumor-targeted autophagy inhibitors.
  • To develop compounds that selectively inhibit autophagy initiation factors (ULK1/2 and VPS34) in cancer cells.
  • To explore novel therapeutic strategies for oncology.

Main Methods:

  • Design of autophagy initiation factor inhibitors (ULK1/2 and VPS34) with tumor-targeting vectors.
  • Utilized a low-nanomolar ULK1/2 inhibitory scaffold combined with an RGR-sequence targeting peptide.
  • Validated compounds through in vitro, in cellulo, and in vivo preclinical models.

Main Results:

  • Developed promising tumor-targeted autophagy inhibitors.
  • Demonstrated selective activity of the compounds in preclinical models.
  • Showcased preserved efficacy of the inhibitors in targeting tumor-specific autophagy.

Conclusions:

  • The developed compounds are the first examples of tumor-targeted autophagy inhibitors.
  • These inhibitors offer a new approach for tissue-specific modulation of autophagy.
  • Potential applications exist in oncology and other fields requiring autophagy regulation.